Technological Advancements To Boost The Growth Of Orthobiological Products Market

According to a recently published report, the global Orthobiological Products Market is expected to grow with a CAGR of 10% during the forecast period of 2016-2022. The global orthobiological product market is segmented on the basis of application, product, and geography. The report on global orthobiological products forecast 2016-2022 (by application, product, and geography) provides a detailed overview and predictive analysis of the market.

Full report available global orthobiological products forecast 2016-2022 (by application, product, and geography) report at

Rapid technological advancements are expected to boost the demand for the orthobiological products market. Autografts was the gold standard of bone grafts, which have many limitations. As a consequence, new orthobiological products have been developed for the benefit of patients and surgeons. Advancements in graft design and biomaterials have allowed these advanced products that mimic the natural human bone and boost bone repair and regeneration.

It has also been found that polymer biomaterial and novel ceramic technologies have developed the osteoinduction biocompatibility and osteoconduction of bone grafts. Other breakthrough technologies like stem cells, 3D printing and nanotechnology have allowed not only curing but remodeling of the bone, thus alluring surgeons and patients searching for improved clinical outcomes.

In addition, procedural volumes are rising due to the growth in elderly population and their concerned bone issues such as osteoarthritis and osteoporosis, which is fuelling the growth in the bone healing market.

Generally, the high cost of novel bone grafts have posed some difficulties in achieving reimbursement, resulting in poor acceptance rates in economically weak nations. Insufficient clinical trial data, which is important while going through the stringent regulatory approval process, is another key challenge for the industry.

The industry needs to perform advanced clinical studies that authenticate the security and merit of bone healing products to take approval from regulatory authorities and reimbursement companies.

Orthobiological products manufacturers should also apply competitive pricing strategies to fuel market penetration and technology acceptance. This will decrease customers’ inclination to use less expensive substitutes that are not technologically advanced. Thus, technological advancements are the key factor for the growth of the orthobiological products market.

Scope of the Report

1. Global Orthobiological Products Market by Application 2012-2022 ($ Million)
1.1. Reconstructive Surgeries
1.2. Trauma
1.3. Spinal Fusion
1.4. Tendon & Ligament Repair
1.5. Other Applications

2. Global Orthobiological Products Market by Product 2012-2022 ($ Million)
2.1. DBM (Demineralized Bone Matrix)
2.2. Allograft
2.3. BMP (Bone Morphogenetic Protein)
2.4. Viscosupplementation
2.5. Machined Bones
2.6. Stem Cell Therapy
2.7. Other Products

3. Global Orthobiological Products Market Regional Outlook 2012-2022 ($ Million)
3.1. North America
3.2. Europe
3.3. Asia Pacific
3.4. Middle East & Africa
3.5. Latin America

4. Competitive Landscape
4.1. Baxter International, Inc.
4.2. Berkeley Advanced Biomaterials, Inc.
4.3. Bioventus
4.4. Bone Biologics, Inc.
4.5. DePuy Synthes, Inc.
4.6. Integra Life Sciences Corp.
4.7. Interventional Spine, Inc.
4.8. Medtronic, Inc.
4.9. Osiris Therapeutics, Inc.
4.10. Pioneer Surgical Technology
4.11. Sanofi
4.12. Smith and Nephew Plc
4.13. Stryker Corp.
4.14. Tissue Banks International
4.15. Tissue Genesis, Inc.